Algorithmic examination

Using machine learning to predict sepsis

A machine-learning algorithm has the capability to identify hospitalized patients at risk for severe sepsis and septic shock using data from electronic health records (EHRs), according to a study presented at the 2017 American Thoracic Society International Conference. Sepsis is an extreme systemic response to infection, which can be life-threatening in its advanced stages of severe sepsis and septic shock, if left untreated.

Machine learning may be used to predict severe sepsis and septic shock in...
Machine learning may be used to predict severe sepsis and septic shock in patients.
Source: ATS

“We have developed and validated the first machine-learning algorithm to predict severe sepsis and septic shock in a large academic multi-hospital healthcare system,” said lead author Heather Giannini, MD, of the Hospital of the University of Pennsylvania. “This is a breakthrough in the use of machine learning technology, and could change the paradigm in early intervention in sepsis.” Machine learning is a type of artificial intelligence that provides computers with the ability to learn complex patterns in data without being explicitly programmed, unlike simpler rule-based systems. Earlier studies have used electronic health record data to trigger alerts to detect clinical deterioration in general.

The researchers developed a machine-learning algorithm to predict patients most at risk for severe sepsis or septic shock, and to use their electronic health record to alert the care team. To develop the algorithm, they trained a random forest classifier, an approach to classify a wide range of data, to sort through electronic health record data for 162,212 patients discharged between July 2011 and June 2014 from three University of Pennsylvania Health System acute care hospitals. The algorithm was able to examine hundreds of variables on a continuous basis. Patients with severe sepsis or septic shock were labeled as such 12 hours before the actual onset of severe sepsis or septic shock. The onset was determined based on lab results and physiological data, such as blood pressure. A total of 943 patients in the database met the assigned lab or physiological criteria.

The algorithm was validated in real time between October and December 2015 with 10,448 patients while they were cared for in the study hospitals, using a “silent mode” of electronic health record sampling. Approximately 3 percent of all acute care patients screened as positive, and 10 alerts were sent each day across the three hospitals. “We were hoping to identify severe sepsis or sepic shock when it was early enough to intervene and before any deterioration started,” said senior author Craig Umscheid, MD, of the Hospital of the University of Pennsylvania. “The algorithm was able to do this. This is a breakthrough in showing that machine learning can accurately identify those at risk of severe sepsis and septic shock.” Dr. Umscheid added that the next steps are to examine process and outcome changes resulting from the use of this machine-learning algorithm, and to see if the algorithm has an impact in clinical practice.

 

Source: American Thoracic Society (ATS)

27.05.2017

Read all latest stories

Related articles

Machine learning

Google AI now can predict cardiovascular problems from retinal scans

Google AI has made a breakthrough: successfully predicting cardiovascular problems such as heart attacks and strokes simply from images of the retina, with no blood draws or other tests necessary.…

Auditory Attention Decoding

Hearing aid uses deep neural network to filter out the noise

Columbia Engineers make major advance in helping the hearing impaired follow a conversation in a noisy environment - and bring cognitive hearing aids a step closer to reality.

E. Coli

The ideal transport vehicle for next-gen vaccines?

Most people recoil at the thought of ingesting E. coli. But what if the headline-grabbing bacteria could be used to fight disease? Researchers experimenting with harmless strains of E. coli — yes,…

Related products

Research use only (RUO)

Eppendorf - Mastercycler nexus X2

Eppendorf AG

Research use only (RUO)

SARSTEDT - Low DNA Binding Micro Tubes

SARSTEDT AG & CO.

Research use only (RUO)

Shimadzu - CLAM-2000

Shimadzu Europa GmbH